Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Lipid metabolism disorders
ADR ID BADD_A01285
ADR Hierarchy
14      Metabolism and nutrition disorders
14.08      Lipid metabolism disorders
Description Pathological conditions resulting from abnormal anabolism or catabolism of lipids in the body. [MeSH]
MedDRA Code 10013317
MeSH ID D052439
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Lipid Metabolism Disorders | Lipid Metabolism Disorder | Metabolism Disorder, Lipid | Metabolism Disorders, Lipid
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01318Lorazepam0.000031%
BADD_D01322Losartan0.000025%
BADD_D01330Lurasidone--
BADD_D01352Maraviroc--
BADD_D01358Mecasermin--
BADD_D01366Medroxyprogesterone acetate--
BADD_D01373Melatonin--
BADD_D01374Meloxicam--
BADD_D01376Melphalan0.000112%
BADD_D01378Memantine--
BADD_D01379Memantine hydrochloride--
BADD_D01392Mercaptopurine--
BADD_D01401Metformin0.000071%
BADD_D01418Methotrexate--
BADD_D01431Methylphenidate--
BADD_D01433Methylprednisolone0.000032%
BADD_D01434Methylprednisolone acetate--
BADD_D01435Methylprednisolone hemisuccinate--
BADD_D01436Methylprednisolone sodium succinate--
BADD_D01442Metoclopramide0.000196%
BADD_D01445Metoprolol0.000017%
BADD_D01466Milnacipran hydrochloride--
BADD_D01471Minocycline anion--
BADD_D01474Mipomersen sodium--
BADD_D01475Mirabegron--
BADD_D01476Mirtazapine0.000480%
BADD_D01479Mitotane0.000168%
BADD_D01496Montelukast0.000015%
BADD_D01501Moxifloxacin--
BADD_D01502Moxifloxacin hydrochloride--
The 8th Page    First    Pre   8 9 10 11 12    Next   Last    Total 15 Pages
ADReCS-Target
ADR Term Drug Name Target